Business
AstraZeneca moves to start making a profit from its vaccine – Sydney Morning Herald
After looking on as Pfizer and Moderna have made billions of dollars in sales, AstraZeneca is shifting to a for-profit model.
The vaccine isnt yet authorised in the US, after the company missed the window for an emergency authorisation due to the complicated nature of its trial results. Astra is planning to submit the shot for approval to regulators in the first half of next year,…
Continue Reading
-
General21 hours agoInternal Revenue Service starts cutting 20,000 workers
-
Noosa News21 hours agoMan killed, woman seriously injured in collision in Wongabel, Atherton Tablelands, Queensland
-
Noosa News20 hours agoMoreton Bay oyster farm survives cyclone with help of wave wall innovation
-
Business22 hours ago$10,000 invested in ANZ shares 5 years ago is now worth…